Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
ILMN

ILMN - Illumina Inc Stock Price, Fair Value and News

111.12USD-3.34 (-2.92%)Market Closed

Market Summary

ILMN
USD111.12-3.34
Market Closed
-2.92%

ILMN Alerts

  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

ILMN Stock Price

View Fullscreen

ILMN RSI Chart

ILMN Valuation

Market Cap

17.7B

Price/Earnings (Trailing)

-13.72

Price/Sales (Trailing)

3.94

EV/EBITDA

-19.8

Price/Free Cashflow

48.36

ILMN Price/Sales (Trailing)

ILMN Profitability

Operating Margin

61.35%

EBT Margin

-25.54%

Return on Equity

-22.5%

Return on Assets

-12.85%

Free Cashflow Yield

2.07%

ILMN Fundamentals

ILMN Revenue

Revenue (TTM)

4.5B

Rev. Growth (Yr)

-1.01%

Rev. Growth (Qtr)

-4.1%

ILMN Earnings

Earnings (TTM)

-1.3B

Earnings Growth (Yr)

-4.3K%

Earnings Growth (Qtr)

28.41%

Breaking Down ILMN Revenue

Last 7 days

0.5%

Last 30 days

-6.1%

Last 90 days

-22.5%

Trailing 12 Months

-44.8%

How does ILMN drawdown profile look like?

ILMN Financial Health

Current Ratio

1.75

ILMN Investor Care

Shares Dilution (1Y)

0.76%

Diluted EPS (TTM)

-8.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20244.5B000
20234.4B4.5B4.5B4.5B
20224.7B4.7B4.7B4.6B
20213.5B4.0B4.3B4.5B
20203.6B3.4B3.2B3.2B
20193.4B3.4B3.5B3.5B
20182.9B3.1B3.2B3.3B
20172.4B2.5B2.6B2.8B
20162.3B2.3B2.4B2.4B
20152.0B2.1B2.1B2.2B
20141.5B1.6B1.7B1.9B
20131.2B1.3B1.3B1.4B
20121.0B1.0B1.1B1.1B
2011993.1M1.1B1.1B1.1B
2010692.7M743.1M822.0M902.7M
20090604.3M635.3M666.3M
2008000573.2M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Illumina Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 06, 2024
wedel christensen jakob
acquired
-
-
3,657
svp, strategy/corp development
May 06, 2024
dhingra ankur
acquired
-
-
8,826
svp, chief financial officer
Apr 05, 2024
rollins carissa
sold (taxes)
-15,585
127
-122
svp, chief information officer
Mar 28, 2024
ullem scott b.
acquired
22,442
137
163
-
Mar 05, 2024
pegels kevin carl
acquired
-
-
5,569
chief of global operations
Mar 05, 2024
leckman patricia
acquired
-
-
7,054
svp, chief people officer
Mar 05, 2024
thaysen jacob
acquired
-
-
29,702
chief executive officer
Mar 05, 2024
rollins carissa
acquired
-
-
5,569
svp, chief information officer
Mar 05, 2024
ericksen scott d
acquired
-
-
2,971
vp, chief accounting officer
Mar 05, 2024
dadswell charles
acquired
-
-
6,683
svp, general counsel

1–10 of 50

Which funds bought or sold ILMN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 16, 2024
Motley Fool Asset Management LLC
added
8.67
43,075
643,756
0.04%
May 16, 2024
Ancora Advisors LLC
reduced
-56.02
-28,150
21,559
-%
May 16, 2024
Wiser Advisor Group LLC
reduced
-20.43
-46,065
167,944
0.26%
May 16, 2024
COMERICA BANK
added
22.17
748,550
4,403,760
0.02%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
added
0.42
-338,817
34,828,300
0.04%
May 16, 2024
Meiji Yasuda Life Insurance Co
unchanged
-
-3,825
273,541
0.01%
May 16, 2024
Tidal Investments LLC
added
51.18
449,289
1,361,170
0.02%
May 16, 2024
Beacon Capital Management, LLC
sold off
-100
-4,530
-
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-85.26
-57,009,500
9,694,240
-%
May 16, 2024
LBP AM SA
added
99.49
418,626
851,384
0.03%

1–10 of 42

Are Funds Buying or Selling ILMN?

Are funds buying ILMN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ILMN
No. of Funds

Unveiling Illumina Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.45%
18,177,520
SC 13G/A
Jan 25, 2024
blackrock inc.
8.4%
13,302,678
SC 13G/A
Dec 05, 2023
baillie gifford & co
3.36%
5,332,416
SC 13G/A
Nov 20, 2023
baillie gifford & co
5.44%
8,608,269
SC 13G/A
Oct 10, 2023
vanguard group inc
11.35%
17,966,765
SC 13G/A
Feb 14, 2023
edgewood management llc
4.1%
6,478,370
SC 13G/A
Feb 09, 2023
vanguard group inc
8.28%
13,022,627
SC 13G/A
Jan 31, 2023
blackrock inc.
7.7%
12,051,653
SC 13G/A
Jan 20, 2023
baillie gifford & co
10.64%
16,743,103
SC 13G/A
Feb 14, 2022
edgewood management llc
5.6%
8,742,202
SC 13G

Recent SEC filings of Illumina Inc

View All Filings
Date Filed Form Type Document
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 17, 2024
4
Insider Trading
May 08, 2024
4
Insider Trading

Peers (Alternatives to Illumina Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
196.9B
23.7B
11.04% 17.40%
44.73
8.29
-8.94% -35.91%
45.2B
6.7B
14.64% 19.44%
36.57
6.71
-2.81% -6.58%
44.9B
3.7B
13.71% 10.52%
51.83
12.06
8.57% 23.94%
16.0B
9.3B
13.66% 10.24%
18.95
1.73
-3.29% 6.68%
13.1B
1.2B
17.80% 114.36%
-35.76
10.81
39.26% 33.08%
12.2B
2.0B
2.71% 87.82%
38.94
6.2
25.57% 21.62%
11.4B
4.1B
-3.66% 11.24%
26.02
2.78
0.49% -11.59%
9.3B
2.5B
-20.33% -38.03%
-38.69
3.67
15.21% 53.51%
MID-CAP
3.1B
603.7M
54.73% -14.09%
-6.73
5.14
25.21% 30.68%
2.9B
929.2M
11.70% -18.80%
1.9K
3.16
28.93% 111.61%
SMALL-CAP
808.3M
275.1M
87.44% 103.94%
-4.41
2.94
-13.93% -126.97%
84.8M
31.1M
-3.25% -85.34%
-1.1
2.73
0.95% 19.75%
33.0M
9.2M
-24.07% -37.65%
-2.24
3.6
11.85% 45.80%
2.5M
5.5M
-62.31% 120.18%
-0.2
0.45
-68.52% -141.15%
183.8K
25.9M
-50.00% -94.83%
-0.01
0.01
-57.78% -93.11%

Illumina Inc News

Latest updates
MarketWatch16 hours ago
StockNews.com14 May 202402:12 pm
Simply Wall St20 Mar 202407:00 am

Illumina Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-4.1%1,0761,1221,1191,1761,0871,0841,1151,1621,2231,1991,1081,1261,093953794633859953907838846
Cost Of Revenue-8.8%409449435444432411398395408382338324329323268205240290259265262
Gross Profit-1.0%667674684732655673717767815818770802764630526428619662648573584
Operating Expenses-7.0%7788371,4388207198004,3741,3466317761,315615571497364332430394340368380
  S&GA Expenses-9.1%439483303450378433146410308426879413374298192177274233189202211
  R&D Expenses-0.4%339341315358341346325327323350436202197199172155156161151166169
EBITDA Margin-4.4%-0.19*-0.18*-0.18*-0.83*-0.97*-0.89*-0.82*0.05*0.23*0.25*0.31*0.28*---------
Interest Expenses-2.7%18.0019.0019.0019.0020.009.006.006.006.0013.0014.0016.0019.0016.0011.0011.0011.0011.0011.0015.0015.00
Income Taxes112.5%17.008.00-28.00145-81.00-28.50144-10254.00-25.5010322.0022.0042.0036.001185.0030.0036.0053.009.00
Earnings Before Taxes34.9%-109-167-782-89.00-78.00-167-3,672-63714087.00420207169299215165178269270346233
EBT Margin-3.0%-0.26*-0.25*-0.25*-0.90*-1.02*-0.95*-0.87*0.00*0.18*0.20*0.26*0.22*---------
Net Income28.4%-126-176-754-2343.00-139-3,816-53586.0011331718514725717947.00173239234296233
Net Income Margin-11.4%-0.29*-0.26*-0.25*-0.94*-1.01*-0.96*-0.88*0.00*0.15*0.17*0.21*0.19*---------
Free Cashflow-76.3%41.0017394.0058.00-42.0059.00-11854.00111212-324209---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-0.7%10,04010,11110,12211,77411,81112,25211,25615,44815,27415,21715,0638,6758,7557,5857,4047,2487,2617,3167,0896,9737,390
  Current Assets-1.0%2,5832,6092,5063,2233,1723,5612,4872,8912,7552,7132,4515,3105,6424,4834,3294,1944,3244,4514,2224,1564,545
    Cash Equivalents5.7%1,1081,0489271,5531,4942,0111,0001,2891,3511,2321,0804,1964,4331,8101,7611,7701,9912,0421,8151,9432,270
  Inventory-0.5%584587615617586568559518465431401380364372415435384359417420412
  Net PPE-4.3%9641,0071,0401,0691,0821,0911,0681,0551,0341,0241,009915915922910890890889875854852
  Goodwill0%2,5452,5452,5273,2393,2393,2393,2387,1587,1137,1137,098966897897897894824897824824831
  Current Liabilities-6.1%1,4741,5701,4822,3032,2302,7732,6692,8811,4901,0939148741,2681,2441,1151,1151,0546656196121,241
  Long Term Debt---------7467026946876806736666596521,1411,1311,1201,112
    LT Debt, Current----750749748747746499---488511507503499---631
    LT Debt, Non Current---------7467026946876806736666596521,1411,1311,1201,112
Shareholder's Equity-0.2%5,7345,7455,8986,5556,6936,5996,73110,44410,89510,74010,5935,1804,9224,6944,7004,5634,6354,6134,4394,3324,070
  Retained Earnings-663.2%-145-19.001579111,1451,1421,2815,0975,6325,4855,3725,0554,8704,7234,4664,2874,2404,0673,8283,5943,298
  Additional Paid-In Capital1.1%9,6589,5559,4879,3979,3119,2079,1299,0338,9578,9388,8493,9933,9143,8153,7373,6493,6313,5603,5103,4363,385
Accumulated Depreciation-100.0%-1,138---962---796---678-------
Shares Outstanding0%159159158158158158157157157150148146---------
Minority Interest---------------------85.00
Float----26,500---26,100---60,200---46,200---48,200-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-65.6%77.0022413910510.00147-52.00125172282-272253282406153240281443267143198
  Share Based Compensation2.1%96.0094.0087.0010693.0010083.0091.0092.0098.0050980.0067.0078.0061.0016.0039.0049.0046.0048.0051.00
Cashflow From Investing43.5%-48.00-85.00-53.00-37.00-56.00-102-250-165-74.00--2,4483.001,376-34.00-65.00-320-135-104-21879.00988
Cashflow From Financing229.6%35.00-27.00-707-3.00-47395628.00-5.0021.00-129-394-496968-331-101-143-191-115-173-549-60.00
  Buy Backs--------------28112514218863.00198-63.00
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

ILMN Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
Apr. 02, 2023
Revenue:  
Total revenue$ 1,076$ 1,087
Cost of revenue:  
Amortization of acquired intangible assets4848
Total cost of revenue409432
Gross profit667655
Operating expense:  
Research and development339341
Selling, general and administrative439378
Total operating expense778719
Loss from operations(111)(64)
Other income (expense):  
Interest income1217
Interest expense(18)(20)
Other income (expense), net8(11)
Total other income (expense), net2(14)
Loss before income taxes(109)(78)
Provision (benefit) for income taxes17(81)
Net (loss) income$ (126)$ 3
(Loss) earnings per share:  
Basic (in dollars per share)$ (0.79)$ 0.02
Diluted (in dollars per share)$ (0.79)$ 0.02
Shares used in computing (loss) earnings per share:  
Basic (in shares)159158
Diluted (in shares)159158
Product revenue  
Revenue:  
Total revenue$ 876$ 922
Cost of revenue:  
Cost of revenue255285
Service and other revenue  
Revenue:  
Total revenue200165
Cost of revenue:  
Cost of revenue$ 106$ 99

ILMN Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 1,108$ 1,048
Accounts receivable, net635734
Inventory, net584587
Prepaid expenses and other current assets256240
Total current assets2,5832,609
Property and equipment, net9641,007
Operating lease right-of-use assets550544
Goodwill2,5452,545
Intangible assets, net2,9402,993
Other assets458413
Total assets10,04010,111
Current liabilities:  
Accounts payable201245
Accrued liabilities1,2731,325
Total current liabilities1,4741,570
Operating lease liabilities700687
Term notes1,4901,489
Other long-term liabilities642620
Stockholders’ equity:  
Common stock22
Additional paid-in capital9,6589,555
Accumulated other comprehensive income (loss)12(1)
Accumulated deficit(145)(19)
Treasury stock, at cost(3,793)(3,792)
Total stockholders’ equity5,7345,745
Total liabilities and stockholders’ equity$ 10,040$ 10,111
ILMN
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
 CEO
 WEBSITEillumina.com
 INDUSTRYDiagnostics & Research
 EMPLOYEES11500

Illumina Inc Frequently Asked Questions


What is the ticker symbol for Illumina Inc? What does ILMN stand for in stocks?

ILMN is the stock ticker symbol of Illumina Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Illumina Inc (ILMN)?

As of Fri May 17 2024, market cap of Illumina Inc is 17.7 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart for subscribers.

What is the fair value of ILMN stock?

You can check ILMN's fair value in chart for subscribers. The fair value of Illumina Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Illumina Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ILMN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Illumina Inc a good stock to buy?

The fair value guage provides a quick view whether ILMN is over valued or under valued. Whether Illumina Inc is cheap or expensive depends on the assumptions which impact Illumina Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ILMN.

What is Illumina Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, ILMN's PE ratio (Price to Earnings) is -13.72 and Price to Sales (PS) ratio is 3.94. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ILMN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Illumina Inc's stock?

In the past 10 years, Illumina Inc has provided -0.028 (multiply by 100 for percentage) rate of return.